TI
MED icon

Trexquant Investment’s Medifast MED Stock Holding History

Trexquant Investment’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.26M Buy
212,684
+32,603
+18% +$376K 0.01% 1143
2026
Q1 		$1.84M Buy
180,081
+53,122
+42% +$573K 0.01% 1035
2025
Q4 		$1.36M Buy
126,959
+59,439
+88% +$711K 0.01% 1097
2025
Q3 		$923K Sell
67,520
-31,086
-32% -$434K 0.01% 1175
2025
Q2 		$1.39M Buy
98,606
+63,069
+177% +$829K 0.02% 1008
2025
Q1 		$479K Sell
35,537
-22,767
-39% -$342K 0.01% 1284
2024
Q4 		$1.03M Sell
58,304
-47,206
-45% -$876K 0.01% 1097
2024
Q3 		$2.02M Buy
105,510
+4,905
+5% +$94.5K 0.03% 807
2024
Q2 		$2.2M Buy
100,605
+57,998
+136% +$1.55M 0.03% 711
2024
Q1 		$1.63M Buy
+42,607
New +$2.06M 0.03% 727
2023
Q3 		– Sell
-11,760
Closed -$1.08M – 1677
2023
Q2 		$1.08M Buy
+11,760
New +$1.05M 0.03% 728
2023
Q1 		– Sell
-8,288
Closed -$956K – 1634
2022
Q4 		$956K Buy
8,288
+2,437
+42% +$284K 0.03% 663
2022
Q3 		$634K Buy
+5,851
New +$838K 0.02% 710
2021
Q2 		– Sell
-3,205
Closed -$679K – 1329
2021
Q1 		$679K Buy
+3,205
New +$767K 0.06% 398
2020
Q2 		– Sell
-9,397
Closed -$587K – 1340
2020
Q1 		$587K Buy
+9,397
New +$856K 0.04% 608
2019
Q1 		– Sell
-3,496
Closed -$437K – 1171
2018
Q4 		$437K Buy
+3,496
New +$598K 0.03% 654
2018
Q2 		– Sell
-10,181
Closed -$951K – 1078
2018
Q1 		$951K Buy
+10,181
New +$761K 0.07% 421
2016
Q2 		– Sell
-11,339
Closed -$342K – 999
2016
Q1 		$342K Buy
11,339
+3,139
+38% +$91.7K 0.04% 698
2015
Q4 		$249K Buy
+8,200
New +$244K 0.02% 897

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Trexquant Investment's MED Position: Q2 2026 in Review

Trexquant Investment increased its Medifast (MED) stake by 18% in Q2 2026, buying an estimated $376K and bringing the position to 212,684 shares worth $2.26M. The position accounts for 0.01% of the portfolio, ranked #1143.

Trexquant Investment first reported a position in MED in Q4 2015 and has held it in 19 quarters since. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Trexquant Investment held 212,684 shares of Medifast worth $2.26M as of Q2 2026.
  • Trexquant Investment bought 32,603 Medifast shares in Q2 2026, an estimated $376K.
  • Medifast made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1143 holding.
  • Trexquant Investment first reported a position in Medifast in Q4 2015 and has held it in 19 quarters since.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.